Faivre Jean, Bossard Nadine, Jooste Valérie
aDigestive cancer registry of Burgundy F-21079, INSERM U866, CHU Dijon, University of Burgundy bDepartment of Biostatistics, University Hospital of Lyon cUniversity of Lyon, Lyon dUniversity of Lyon 1, Lyon eCNRS, UMR5558, Biometry and Evolutionary Biology laboratory (LBBE), BioMaths-Health Department, Villeurbanne, France.
Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S40-S47. doi: 10.1097/CEJ.0000000000000293.
Colon cancer represents a major public health issue. The aim of the SUDCAN collaborative study was to compare the net survival from colon cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) and provide trends in net survival and dynamics of the excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. Results were reported from 1992 to 2004 in France, Italy, Spain, and Switzerland and from 2000 to 2004 in Belgium and Portugal. These analyses were carried out using a flexible excess rate modeling strategy. There were few differences between countries in age-standardized net survivals (2000-2004). During the 2000-2004 period, the 5-year net survival ranged between 57 (Spain and Portugal) and 61% (Belgium and Switzerland). The age-standardized survival at 1 and 5 years after diagnosis increased between 1992 and 2004. This increase was observed at ages 60 and 70, but was less marked at 80. This increase was linked to a marked decrease in the excess mortality rate between 1992 and 2004 until 18 months after diagnosis. Beyond this period, the decrease in the excess mortality rates among countries was modest and nearly the same whatever the year of diagnosis. There were minor differences in survival after colon cancer between European Latin countries. A considerable improvement in the 5-year net survival was observed in all countries, but the gain was mainly limited to the first 18 months after diagnosis. Further improvements are expected through the implementation of mass screening programs.
结肠癌是一个重大的公共卫生问题。SUDCAN合作研究的目的是比较六个欧洲拉丁国家(比利时、法国、意大利、葡萄牙、西班牙和瑞士)结肠癌的净生存率,并提供净生存率趋势以及诊断后长达5年的超额死亡率动态变化。数据取自EUROCARE - 5数据库。首先,使用波哈尔 - 佩尔梅估计量研究了2000 - 2004年期间的净生存率。对于趋势分析,研究时期因国家而异。法国、意大利、西班牙和瑞士报告了1992年至2004年的结果,比利时和葡萄牙报告了2000年至2004年的结果。这些分析采用了灵活的超额率建模策略。各国年龄标准化净生存率(2000 - 2004年)之间差异不大。在2000 - 2004年期间,5年净生存率在57%(西班牙和葡萄牙)至61%(比利时和瑞士)之间。诊断后1年和5年的年龄标准化生存率在1992年至2004年有所提高。这种提高在60岁和70岁人群中可见,但在80岁人群中不太明显。这种提高与1992年至2004年直至诊断后18个月超额死亡率的显著下降有关。在此之后,各国超额死亡率的下降幅度较小,且无论诊断年份如何几乎相同。欧洲拉丁国家之间结肠癌后的生存率存在细微差异。所有国家的5年净生存率都有显著提高,但这种提高主要局限于诊断后的前18个月。通过实施大规模筛查计划有望进一步改善。